• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Cough, Cold and Allergy (Hay Fever) Remedies in Germany Product Image

Cough, Cold and Allergy (Hay Fever) Remedies in Germany

  • Published: August 2013
  • Region: Europe, Germany
  • 46 Pages
  • Euromonitor International

FEATURED COMPANIES

  • Arzneimittel GmbH & Co
  • Dr Soldan GmbH
  • Krewel Meuselbach GmbH
  • Merck KGaA
  • Pharma GmbH & Co KG
  • Ricola AG
  • MORE

As in every year, the main influence on retail value sales of cough, cold and allergy (hay fever) remedies in Germany is exerted by environmental conditions such as climate and seasonal change, pollen levels and the spread of flu, as well as urban pollution. 2012 saw a rather positive (in favour of the category) impact from that side and consequently a growth of OTC sales of cough, cold and allergy remedies.

The Cough, Cold and Allergy (Hay Fever) Remedies in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Cough, Cold and Allergy READ MORE >

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN GERMANY

August 2013

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2007-2012
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2007-2012
Table 3 Sales of Decongestants by Category: Value 2007-2012
Table 4 Sales of Decongestants by Category: % Value Growth 2007-2012
Table 5 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2007-2012
Table 6 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2007-2012
Table 7 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2008-2012
Table 8 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2009-2012
Table 9 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2012-2017
Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2012-2017
Bayer Vital GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 1 Bayer Vital GmbH: Key Facts
Summary 2 Bayer Vital GmbH: Operational Indicators
Company Background
Production
Summary 3 Bayer Vital GmbH: Production Statistics 2012
Competitive Positioning
Summary 4 Bayer Vital GmbH: Competitive Position 2012
Boehringer Ingelheim Pharma GmbH & Co Kg in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 5 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts
Summary 6 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators
Company Background
Production
Summary 7 Boehringer Ingelheim Pharma GmbH & Co KG: Production Statistics 2012
Competitive Positioning
Summary 8 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2012
GlaxoSmithKline GmbH & Co Kg in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 9 GlaxoSmithKline GmbH & Co KG: Key Facts
Summary 10 GlaxoSmithKline GmbH & Co KG: Operational Indicators
Company Background
Production
Summary 11 GlaxoSmithKline GmbH & Co KG: Production Statistics 2012
Competitive Positioning
Summary 12 GlaxoSmithKline GmbH & Co KG: Competitive Position 2012
Hexal AG in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 13 Hexal AG: Key Facts
Summary 14 Hexal AG: Operational Indicators
Company Background
Production
Summary 15 Hexal AG: Production Statistics 2012
Competitive Positioning
Summary 16 Hexal AG: Competitive Position 2012
Johnson & Johnson GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 17 Johnson & Johnson GmbH: Key Facts
Company Background
Production
Competitive Positioning
Summary 18 Johnson and Johnson: Competitive Position 2012
Mcm Klosterfrau Vertriebsgesellschaft Mbh in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 19 MCM Klosterfrau Vertriebsgesellschaft mbH: Key Facts
Summary 20 MCM Klosterfrau Vertriebsgesellschaft mbH: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 21 MCM Klosterfrau Vertriebsgesellschaft mbH: Competitive Position 2012
Novartis Consumer Health GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 22 Novartis Consumer Health GmbH: Key Facts
Summary 23 Novartis Consumer Health GmbH: Operational Indicators
Company Background
Production
Summary 24 Novartis Consumer Health GmbH: Production Statistics 2012
Competitive Positioning
Summary 25 Novartis Consumer Health GmbH: Competitive Position 2012
Pgt Healthcare in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 26 PGT Healthcare: Key Facts
Company Background
Production
Summary 27 PGT Healthcare: Production Statistics 2012
Competitive Positioning
Summary 28 PGT Healthcare: Competitive Position 2012
Stada Arzneimittel AG in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 29 Stada Arzneimittel AG: Key Facts
Summary 30 Stada Arzneimittel AG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 31 Stada Arzneimittel AG: Competitive Position 2012
Executive Summary
Market Saturation Limits Growth Opportunities in 2012
Vitamins and Dietary Supplements Loses Out, Whilst Sports Nutrition Booms
Multinationals Continue To Lead Consumer Health
Internet Retailing on the Rise
Less Rosy Future of Consumer Health Expected
Key Trends and Developments
New Economic Crisis Has Not Reached Germany (yet?)
Changing Roles and Organisational Forms of Chemists/pharmacies in Germany
Brands Need Constant Innovation in Order To Thrive (or at Least Survive)
Increasing Number of Negative Media Reports About Self-medication Products
Growing Fitness Trend Boosts Demand for Sports Nutrition Products
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 32 OTC: Switches 2010-2012
Market Indicators
Table 11 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 12 Life Expectancy at Birth 2007-2012
Market Data
Table 13 Sales of Consumer Health by Category: Value 2007-2012
Table 14 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 15 Consumer Health Company Shares 2008-2012
Table 16 Consumer Health Brand Shares 2009-2012
Table 17 Penetration of Private Label by Category 2007-2012
Table 18 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 19 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 20 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Sources
Summary 33 Research Sources

Consumer attitudes towards self-medication
According to industry experts, three quarters of the German population over the age of 15 years old selfmedicate. It is estimated that around 50% of the population regularly use self-medication products for health maintenance and sickness prevention, making a considerable contribution to public health and alleviating pressure on the state healthcare budget.

Consumers’ income elasticity regarding preventive products (vitamins, minerals and natural mineral water, etc) is greater than that for therapeutic medicines in Germany. Knowledge about medicines is increasing all the time, forming a solid basis for the appropriate use of medicines for the purposes of self-medication. The majority of German consumers regard themselves as well informed about medicines. German consumers are typically able to ask for OTC products by name, and are showing increasing brand loyalty.

Companies Mentioned Include:
- Bayer Vital GmbH
- Novartis Consumer Health GmbH
- Boehringer Ingelheim
- Pharma GmbH & Co KG
- Beiersdorf AG
- Ratiopharm GmbH & Co
- Abtei Pharma Vertriebs-GmbH
- Procter & Gamble GmbH
- STADA Arzneimittel AG
- Whitehall Much GmbH
- Bayer Group (Bayer Vital GmbH)
- MCM Klosterfrau Vertriebgesellschaft mbH
- Mann Chem-Pharm Fabrik GmbH, Dr Gerhard
- Madaus AG
- Impuls-Vermarktung GmbH & Co KG
- Spitzner Arzneimittel GmbH
- Boots Healthcare Deutschland GmbH
- Roche Consumer Health Deutschland GmbH
- McNeil GmbH & Co
- Ricola AG
- Aventis Pharma Deutschland GmbH (Nattermann & Cie GmbH)
- Hexal AG
- Pfizer Consumer Healthcare GmbH
- Nattermann & Cie GmbH
- Johnson & Johnson GmbH
- Viatris GmbH & Co KG (formerly known as Asta Medica AG)
- Bad Heilbrunner Naturheilmittel GmbH & Co
- Gödecke AG
- Engelhard Arzneimittel GmbH and Co KG
- Solvay Arzneimittel GmbH
- Merck KGaA
- Lichtwer Pharma AG
- Dr Soldan GmbH
- Merz & Co GmbH & Co
- Milupa GmbH & Co KG
- Krewel Meuselbach GmbH
- Galenika Dr Hetterich GmbH
- Divapharma-Knufinke Arzneimittelwerk GmbH
- Pohl-Boskamp GmbH und Co
- Weleda AG
- Woelm Pharma GmbH & Co Dr Rentschler
- Arzneimittel GmbH & Co
- GlaxoSmithKline GmbH & Co KG
- Wolff GmbH & Co Arzneimittel, Dr August

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos